Home / Sweden / Immunicum Aktiebolag
Immunicum Aktiebolag
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
74 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
August 29, 2019 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 19, 2019 | Citadel Advisors II LLC | 0.00% | still open |
| September 18, 2019 | Squarepoint OPS LLC | 0.83% | still open |
| September 18, 2019 | Citadel Advisors II LLC | 0.59% | still open |
| September 17, 2019 | Squarepoint OPS LLC | 0.83% | still open |
| September 17, 2019 | Citadel Advisors II LLC | 0.59% | still open |
| September 16, 2019 | Citadel Advisors II LLC | 0.63% | still open |
| September 15, 2019 | Citadel Advisors II LLC | 0.63% | still open |
| September 13, 2019 | Squarepoint OPS LLC | 0.70% | still open |
| September 12, 2019 | Citadel Advisors II LLC | 0.59% | still open |
| September 11, 2019 | Squarepoint OPS LLC | 0.61% | still open |
| September 11, 2019 | Citadel Advisors II LLC | 0.59% | still open |
| September 10, 2019 | Marshall Wace LLP | 1.24% | still open |
| September 10, 2019 | Squarepoint OPS LLC | 0.61% | still open |
| September 9, 2019 | Marshall Wace LLP | 1.24% | still open |
| September 6, 2019 | Citadel Advisors II LLC | 0.63% | still open |
| September 6, 2019 | Squarepoint OPS LLC | 0.50% | still open |
| September 5, 2019 | Citadel Advisors II LLC | 0.52% | still open |
| September 4, 2019 | Citadel Advisors II LLC | 0.00% | still open |
| September 3, 2019 | Citadel Advisors II LLC | 0.55% | still open |
| September 2, 2019 | Marshall Wace LLP | 1.15% | still open |
| September 2, 2019 | Citadel Advisors II LLC | 0.55% | still open |
| September 1, 2019 | Marshall Wace LLP | 1.15% | still open |
| August 30, 2019 | Marshall Wace LLP | 0.75% | still open |
| August 29, 2019 | Marshall Wace LLP | 0.75% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.26% of the capital sold short
- Elekta AB (publ) 9.63% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Embracer Group AB 5.75% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- RaySearch Laboratories AB (publ) 4.16% of the capital sold short
- Dynavox Group AB 3.80% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Immunicum Aktiebolag, source Finansinspektionen, data as at September 14, 2020, https://www.quivad.com/action/immunicum-aktiebolag?page=2